INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 69 filers reported holding INOTEK PHARMACEUTICALS CORP in Q1 2017. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $31,000 | -3.1% | 16,217 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $32,000 | -67.7% | 16,217 | 0.0% | 0.00% | -83.3% |
| Q4 2016 | $99,000 | -84.3% | 16,217 | -75.6% | 0.01% | -73.3% |
| Q3 2016 | $631,000 | +27.5% | 66,517 | 0.0% | 0.04% | -11.8% |
| Q2 2016 | $495,000 | +0.6% | 66,517 | 0.0% | 0.05% | +30.8% |
| Q1 2016 | $492,000 | -70.6% | 66,517 | -55.1% | 0.04% | -85.8% |
| Q4 2015 | $1,676,000 | +20.4% | 148,000 | 0.0% | 0.27% | +69.1% |
| Q3 2015 | $1,392,000 | – | 148,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|